| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 02/03/2019 | 01:13 | Dow Jones News | Synergy Pharmaceuticals Is Approved to Sell Assets to Bausch Health | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 27/02/2019 | 01:07 | Dow Jones News | Bausch Health to Acquire Certain Assets of Synergy Pharmaceuticals Inc. | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 17/12/2018 | 21:43 | Dow Jones News | Synergy Pharmaceuticals Up 55% on Trulance Progress in Canada | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 12/12/2018 | 17:10 | Dow Jones News | Former Pharma Highflier Appreciates Bathroom Humor -- Overheard | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 12/12/2018 | 14:18 | Dow Jones News | Bausch Health to Buy Synergy Pharmaceuticals Out of Bankruptcy for $200 Million--Update | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 12/12/2018 | 13:14 | Dow Jones News | Bausch Health Agrees to Buy Synergy Pharmaceuticals for $200 Million | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 03/01/2012 | 22:44 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 27/12/2011 | 22:05 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 22/12/2011 | 12:01 | Edgar (US Regulatory) | Notice of Effectiveness (EFFECT) | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 21/12/2011 | 18:18 | Edgar (US Regulatory) | Prospectus filed pursuant to Rule 424(b)(3) (424B3) | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 19/12/2011 | 23:04 | Edgar (US Regulatory) | Securities Registration Statement (simplified form) (S-3/A) | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 13/12/2011 | 22:41 | Business Wire | Synergy Pharmaceuticals Announces Full Exercise of Over-Allotment Option by Aegis Capital Corp. | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 13/12/2011 | 14:00 | PR Newswire (US) | Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior V... | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 13/12/2011 | 09:00 | Business Wire | Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. & its Chief Scientific Officer & Senior VP of... | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 06/12/2011 | 23:00 | Business Wire | Synergy Pharmaceuticals Announces Closing of Public Offering of 1,875,000 Units | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 01/12/2011 | 23:14 | Edgar (US Regulatory) | Prospectus filed pursuant to Rule 424(b)(2) (424B2) | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |
| 01/12/2011 | 14:00 | Business Wire | Synergy Pharmaceuticals Inc. Announces Pricing of Public Offering of 1,875,000 Units, Listing on NASDAQ & Effectiveness of Re... | NASDAQ:SGYPD | Synergy Pharmaceuticals, Inc. (MM) |